Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA Receptor
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Two metabolites of the steroid hormones progesterone and deoxycorticosterone, 3 alpha-hydroxy-5 alpha-dihydroprogesterone and 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone, are potent barbiturate-like ligands of the gamma-aminobutyric acid (GABA) receptor-chloride ion channel complex. At concentrations between 10(-7) and 10(-5)M both steroids inhibited binding of the convulsant t-butylbicyclophosphorothionate to the GABA-receptor complex and increased the binding of the benzodiazepine flunitrazepam; they also stimulated chloride uptake (as measured by uptake of 36Cl-) into isolated brain vesicles, and potentiated the inhibitory actions of GABA in cultured rat hippocampal and spinal cord neurons. These data may explain the ability of certain steroid hormones to rapidly alter neuronal excitability and may provide a mechanism for the anesthetic and hypnotic actions of naturally occurring and synthetic anesthetic steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Allo acts at nanomolar concentrations as an anesthetic, anxiolytic anticonvulsant by binding to GABA A receptors at sites distinct from those bound by GABA, benzodiazepines, and barbiturates, functioning as an allosteric modulator to open the channel and increase chloride flux (696 -699).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [696]
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
Receptors for the Age of Anxiety: Pharmacology of the Benzodiazepines
Tallman, J. F., Paul, S. M., Skolnick, P., & Gallager, D. W. (1980) · Science · doi:10.1126/science.6101294 · Cited by 862
Self-citationA patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine
Fenwick, E. M., Marty, A., & Neher, E. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014393 · Cited by 812
GABAergic modulation of benzodiazepine binding site sensitivity
TALLMAN, J. F., THOMAS, J. W., & GALLAGER, D. W. (1978) · Nature · doi:10.1038/274383a0 · Cited by 722
DRUG INTERACTIONS AT THE GABA RECEPTOR-IONOPHORE COMPLEX
Olsen, R. W. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.001333 · Cited by 695
Study, R. E., & Barker, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7180 · Cited by 561
Self-citationSquires, R. F., Casida, J. E., Richardson, M., & Saederup, E. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14273-9 · Cited by 551
New concepts on the mechanism of action of benzodiazepines
Costa, E., Guidotti, A., Mao, C. C., & Suria, A. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90501-9 · Cited by 536
Modulation of the GABA receptor complex by a steroid anaesthetic
Harrison, N. L., & Simmonds, M. A. (1984) · Brain Research · doi:10.1016/0006-8993(84)90299-3 · Cited by 499
Self-citationAnnual Review of Pharmacology,
Williams, J. F. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.1975.00330100136032 · Cited by 386
Research works printed but not linked: 15
- ADAMS, P.R., ADVANCES IN PHYSIOLOGICAL SCIENCES 4: 135 (1981).
- BAULIEU, E.E., STEROID HORMONE REGU: 3 (1980).
- FELDMAN, S, INTEGRATIVE NEUROHUM: 173 (1983).
- HAEFELY, W, ANXIOLYTICS NEUROCHE: 113 (1983).
- HARRISON, N.L., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 15: 81 (1985).
- HOLZBAUER, M, J PHYSL LONDON 210: 123 (1970).
- KARAVOLAS, H.J., METABOLISM HORMONAL: 149 (1984).
- Leeb-Lundberg, F., Proceedings of the National Academy of Sciences of the United States of America 77: 7468 (1980).
- MAJEWSKA, M.D., MOL PHARM 25: 353 (1984).
- MCEWEN, B.S., ADRENAL ACTIONS BRAI: 1 (1982).
- RIKKER, J, ADRENAL ACTIONS BRAI: 69 (1982).
- Study, R. E., Proceedings of the National Academy of Sciences of the United States of America 78: 7180 (1981).
- STUMPF, W.E., STEROID HORMONE REGU: 41 (1980).
- TRIFILETTI, R.R., EUR J PHARMACOL 106: 441 (1985).
- Cottrell G. L. Journal of Physiology in press.
Cited by
Items 201–300 of 1,008
Membrane receptors for estrogen, progesterone, and testosterone in the rat brain: Fantasy or reality
Ramirez, V. D., Zheng, J., & Siddique, K. M. (1996) · Cellular and Molecular Neurobiology · doi:10.1007/bf02088175 · Cited by 164
“Also, compounds such as 3a-OH-DHP and hydroxytamoxifen, known to compete with the GABAa receptor (Majewska et al., 1986) and the nuclear estrogen receptor (Sudo et al.”
BackgroundThe Neurosteroid Allopregnanolone Is Reduced in Prefrontal Cortex in Alzheimer’s Disease
Marx, C. E., Trost, W. T., Shampine, L. J., Stevens, R. D., Hulette, C. M., Steffens, D. C., Ervin, J. F., Butterfield, M. I., Blazer, D. G., Massing, M. W., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.017 · Cited by 159
Akwa, Y., Sananès, N., Gouézou, M., Robel, P., Baulieu, E. E., & Le Goascogne, C. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.135 · Cited by 164
“3a, 5ix -TH PROG, known as an anesthetic steroid, binds to GABAA receptor and potentiates GABAergic neurotransmission (Majewska et al., 1986).”
BackgroundInfluentialAkwa, Y., Morfin, R. F., Robel, P., & Baulieu, E. E. (1992) · Biochemical Journal · doi:10.1042/bj2880959 · Cited by 163
Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management
Schweizer, E., & Rickels, K. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb05973.x · Cited by 163
Persistent Sexual Side Effects of Finasteride: Could They be Permanent?
Irwig, M. S. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02846.x · Cited by 162
Alcohol Related Changes in Regulation of NMDA Receptor Functions
Nagy, J. (2008) · Current Neuropharmacology · doi:10.2174/157015908783769662 · Cited by 157
“Neurosteroids known to interact with GABAA and NMDA receptors include: 3 -hydroxy-5pregnen-20-one-3-sulfate (pregnenolone sulfate) (PS); dehydroepiandrosterone sulfate (DHEAS); 3 -hydroxy-5 -pregnan20-one (3 5 allopregnanolone); 3 -hydroxy-5 -pregnan-20one (3 5 pregnanolone) and 3 -hydroxy-5 -pregnan-20-one sulfate (3…”
The neuropsychopharmacological potential of neuroactive steroids
Rupprecht, R. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00060-x · Cited by 162
Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat
Chen, J., Chopp, M., & Li, Y. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00247-6 · Cited by 161
Finasteride, a 5α-Reductase Inhibitor, Blocks the Anticonvulsant Activity of Progesterone in Mice
Kokate, T. G., Banks, M. K., Magee, T., Yamaguchi, S.-I., & Rogawski, M. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38006-1 · Cited by 91
Mechanisms of neurosteroid interactions with GABAA receptors
Akk, G., Covey, D. F., Evers, A. S., Steinbach, J. H., Zorumski, C. F., & Mennerick, S. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.004 · Cited by 159
“TBPS binds to the picrotoxin site of the GABAA receptor/ionophore complex, and neuroactive steroids and other anesthetics are known to allosterically displace TBPS binding (Majewska et al., 1986;Ramanjaneyulu & Ticku, 1984;Ticku & Ramanjaneyulu, 1984).”
BackgroundProgesterone neuroprotection in traumatic CNS injury and motoneuron degeneration
De Nicola, A. F., Labombarda, F., Deniselle, M. C. G., Gonzalez, S. L., Garay, L., Meyer, M., Gargiulo, G., Guennoun, R., & Schumacher, M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.03.001 · Cited by 160
The Effect of Menopause and Perimenopause on the Course of Epilepsy
Harden, C. L., Pulver, M. C., Ravdin, L., & Jacobs, A. R. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02012.x · Cited by 161
“y-aminobutyric acid (GABA) receptor to produce an antiseizure effect (4).”
BackgroundKokate, T. G., Cohen, A. L., Karp, E., & Rogawski, M. A. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00021-4 · Cited by 161
“…metabolites of progesterone (5a,3a-pregnanolone and 5fl,3a-pregnanolone), produce a powerful enhancement of GABA* receptor responses in vitro (Majewska et al., 1986; Harrison et al., 1987; Gee et al., 1988; Peters et al., 1988) and have potent anticonvulsant, anxiolytic and sedative activity…”
BackgroundFrye, C. A., & Duncan, J. E. (1994) · Brain Research · doi:10.1016/0006-8993(94)90025-6 · Cited by 163
Shen, H., Gong, Q. H., Yuan, M., & Smith, S. S. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.026 · Cited by 163
“Unlike most steroids, the THP isomers are potent positive modulators of the GABAA receptor (GABAR) when acutely applied (Belelli et al., 2002; Brown et al., 2002; Majewska et al., 1986; Wohlfarth et al., 2002), an effect which enhances tonic GABAergic current in areas such as dentate gyrus (Stell et al.”
BackgroundFrye, C. A., Bayon, L. E., Pursnani, N. K., & Purdy, R. H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00764-1 · Cited by 162
GABAA‐Receptor δ Subunit Knockout Mice Have Multiple Defects in Behavioral Responses to Ethanol
Mihalek, R. M., Bowers, B. J., Wehner, J. M., Kralic, J. E., VanDoren, M. J., Morrow, A. L., & Homanics, G. E. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02179.x · Cited by 159
“Neurosteroids are synthesized in the brain and are the most potent endogenous modulators of the GABAR identified ( Majewska et al., 1986; Paul and Purdy, 1992).”
BackgroundSocial closeness increases salivary progesterone in humans
Brown, S. L., Fredrickson, B. L., Wirth, M. M., Poulin, M. J., Meier, E. A., Heaphy, E. D., Cohen, M. D., & Schultheiss, O. C. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.03.022 · Cited by 152
“In fact, ALLO has similar efficacy and potency to benzodiazepines at GABA receptors (Majewska et al., 1986).”
BackgroundCorticosteroids in Cancer: Neuropsychiatric Complications
Stiefel, F. C., Breitbart, W. S., & Holland, J. C. (1989) · Cancer Investigation · doi:10.3109/07357908909041378 · Cited by 157
Martinez, P. E., Rubinow, D. R., Nieman, L. K., Koziol, D. E., Morrow, A. L., Schiller, C. E., Cintrón-López, D., Thompson, K., Khine, K., & Schmidt, P. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.246 · Cited by 167
“…(ie, 3α-hydroxy-5α-pregnan-20one), potentially mediates the symptom precipitating effects of progesterone in PMDD. Allopregnanolone regulates central GABA-A receptor function and hence CNS excitation (Majewska et al, 1986; Paul and Purdy, 1992; Maguire et al, 2005; Shen et al, 2007).”
BackgroundMicevych, P. E., & Mermelstein, P. G. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8034-z · Cited by 155
“The capacity of steroidogenesis in the cells of the CNS is widespread, but different cell types appear to preferentially produce specific steroids [84].”
Irwin, R. P., Maragakis, N. J., Rogawski, M. A., Purdy, R. H., Farb, D. H., & Paul, S. M. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90327-4 · Cited by 161
Self-citationThe reproductive brain in fish
Kah, O., Anglade, I., Leprêtre, E., Dubourg, P., & Monbrison, D. D. (1993) · Fish Physiology and Biochemistry · doi:10.1007/bf00004554 · Cited by 153
Topology of ligand binding sites on the nicotinic acetylcholine receptor
Arias, H. R. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00020-9 · Cited by 181
Devaud, L. L., Purdy, R. H., & Morrow, A. L. (1995) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01514.x · Cited by 158
Gonadal Steroid Hormone Receptors and Social Behaviors
Blaustein, J. D., & Olster, D. H. (1989) · Advances in comparative and environmental physiology · doi:10.1007/978-3-642-73827-2_2 · Cited by 161
Neuroendocrine considerations in the treatment of men and women with epilepsy
Harden, C. L., & Pennell, P. B. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70239-9 · Cited by 156
Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology
Rupprecht, R., di Michele, F., Hermann, B., Ströhle, A., Lancel, M., Romeo, E., & Holsboer, F. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00123-0 · Cited by 166
δ Subunit Inhibits Neurosteroid Modulation of GABAAReceptors
Zhu, W. J., Wang, J. F., Krueger, K. E., & Vicini, S. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06648.1996 · Cited by 156
“In different neuronal populations, distinct neurosteroids have specific binding characteristics and may act as positive or negative modulators of GABAA receptor function ( Majewska et al., 1986, 1988; Gee et al., 1988; Puia et al., 1990, 1993; Gee and Lan, 1991; Lan et al., 1991; Shingai et al., 1991; Sapp et al., 199…”
BackgroundNeuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems
Birzniece, V., Bäckström, T. C., Johansson, I., Lindblad, C., Lundgren, P., Löfgren, M., Olsson, T., Ragagnin, G., Taube, M., Türkmen, Ş., et al. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.001 · Cited by 166
Pehrson, A., & Sanchez, C. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s62912 · Cited by 145
“66 Acute allopregnanolone administration also has well-recognized behavioral effects that are consistent with a positive modulatory effect on GABA neurotransmission, including anxiolytic 67 and seizure-reducing 68 properties.”
Sex Differences in the Vomeronasal System
Guillamón, A., & Segovia, S. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00217-7 · Cited by 176
Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes.
Orchinik, M., Murray, T. F., Franklin, P. H., & Moore, F. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3830 · Cited by 149
Picazo, O., & Fernández‐Guasti, A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00254-n · Cited by 155
Verleye, M., Akwa, Y., Lière, P., Ladurelle, N., Pianos, A., Eychenne, B., Schumacher, M., & Gillardin, J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.11.013 · Cited by 148
“Interestingly, under the present conditions, acute etifoxine administration increased the neuroactive steroid allopregnanolone in rat brain to concentrations (0.7–1.5 ng/g or 3–5 nM) known to interact with the GABAA receptor in vitro (Majewska et al., 1986; Morrow et al., 1987).”
BackgroundInfluentialWieland, S., Lan, N. C., Belluzzi, J. D., & Stein, L. (1995) · Psychopharmacology · doi:10.1007/bf02245251 · Cited by 155
“1990), biochemical (Majewska et al. 1986; Gee 1988; Gee et at. 1988; Morrow et al. 1990), and electrophysiological (Peters et al.”
BackgroundGallo, M. A., & Smith, S. S. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90219-j · Cited by 148
Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome
Tiranini, L., & Nappi, R. E. (2022) · Faculty Reviews · doi:10.12703/r/11-11 · Cited by 169
Determination of steroids by liquid chromatography/mass spectrometry
Ma, Y.-C., & Kim, H.-Y. (1997) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(97)00122-0 · Cited by 146
Lawrie, T. A., Justus Hofmeyr, G., De Jager, M., Berk, M., Paiker, J., & Viljoen, E. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb09940.x · Cited by 146
Frye, C. A., Van Keuren, K. R., & Erskine, M. S. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00004-6 · Cited by 146
Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat
Bovolin, P., Schlichting, J., Miyata, M., Ferrarese, C., Guidotti, A., & Alho, H. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90089-f · Cited by 147
Piazza, P. V., Marinelli, M., Jodogne, C., Deroche‐Gamonet, V., Rougé‐Pont, F., Maccari, S., Moal, M. L., & Simon, H. (1994) · Brain Research · doi:10.1016/s0006-8993(09)90034-8 · Cited by 160
Actions of synthetic and endogenous steroids on the GABAA receptor
Lambert, J. J., Peters, J. A., & Cottrell, G. A. (1987) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(87)90067-8 · Cited by 161
Wirth, M. M., & Schultheiss, O. C. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.08.003 · Cited by 159
Pathogenesis in Menstrual Cycle‐Linked CNS Disorders
BÄCKSTRÖM, T., ANDERSSON, A., ANDREÉ, L., BIRZNIECE, V., BIXO, M., BJÖRN, I., HAAGE, D., ISAKSSON, M., JOHANSSON, I., LINDBLAD, C., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.005 · Cited by 143
Role of neurosteroids in catamenial epilepsy
Reddy, D. S. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.09.003 · Cited by 149
Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity
Holsboer, F. (1989) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00449812 · Cited by 159
Structure–function of human 3α-hydroxysteroid dehydrogenases: genes and proteins
Penning, T. M., Jin, Y., Steckelbroeck, S., Rižner, T. L., & Lewis, M. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.006 · Cited by 160
Weis, S., Hausmann, M., Stoffers, B., Vohn, R., Kellermann, T., & Sturm, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4392-08.2008 · Cited by 143
“Receptors of various transmitter systems are fundamentally modulated by gonadal steroid hormones such as estradiol and progesterone (Majewska et al., 1986; Smith et al., 1987a,b, 1988; Smith, 1991).”
BackgroundOlanzapine and Clozapine Increase the GABAergic Neuroactive Steroid Allopregnanolone in Rodents
Marx, C. E., VanDoren, M. J., Duncan, G. E., Lieberman, J. A., & Morrow, A. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300015 · Cited by 148
“…olanzapine and clozapine administration dose-dependently and specifically increases the GABAergic neuroactive steroid allopregnanolone in rat cerebral cortex to concentrations known to potentiate GABAA receptor function (3.0–4.0 ng/g or 10–13 nM) (Majewska et al, 1986; Morrow et al, 1987, 1990).”
BackgroundInfluentialSocial isolation-induced changes in the hypothalamic–pituitary–adrenal axis in the rat
Serra, M., Pisu, M. G., Floris, I., & Biggio, G. (2005) · Stress · doi:10.1080/10253890500495244 · Cited by 142
“…(allopregnanolone or 3a,5a-TH PROG) and 3a,5a-tetrahydrodeoxycorticosterone (3a,5a-TH DOC), are among the most potent positive allosteric modulators of type A receptors for the inhibitory neurotransmitter g-aminobutyric acid (GABA) (Majewska et al. 1986; Belleli and Lambert 2005).”
BackgroundSteroids and their conjugates in the mammalian brain.
Mathur, C., Prasad, V. V., Raju, V. S., Welch, M., & Lieberman, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.85 · Cited by 143
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Henter, I. D., Park, L. T., & Zarate, C. A. (2021) · CNS Drugs · doi:10.1007/s40263-021-00816-x · Cited by 142
“Brexanolone (Zulresso), a neurosteroid derivative of allopregnanolone, acts as a positive allosteric modulator of GABAA receptor function [122]; in contrast to benzodiazepines, positive allosteric modulators bind and trigger the GABAA receptor to open more frequently or for longer periods, but they do not work indepen…”
BackgroundMarx, C. E., Bradford, D. W., Hamer, R. M., Naylor, J. C., Allen, T. B., Lieberman, J. A., Strauss, J. L., & Kilts, J. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.076 · Cited by 160
How Progesterone Impairs Memory for Biologically Salient Stimuli in Healthy Young Women
van Wingen, G., van Broekhoven, F., Verkes, R. J., Petersson, K. M., Bäckström, T., Buitelaar, J., & Fernández, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1715-07.2007 · Cited by 136
“This is likely mediated by the modulation of allopregnanolone on extrasynaptic -subunit containing GABAA receptors, which enhances tonic inhibition and thereby decreases neuronal excitability (Stell et al., 2003).”
BackgroundInfluentialAnticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex
Belelli, D., Lan, N. C., & Gee, K. W. (1990) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80041-7 · Cited by 150
Ukena, K., Kohchi, C., & Tsutsui, K. (1999) · Endocrinology · doi:10.1210/endo.140.2.6516 · Cited by 141
Maurice, T., Gregoire, C. J., & Espallergues, J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.009 · Cited by 161
Low Serum Allopregnanolone Is Associated with Symptoms of Depression in Late Pregnancy
Hellgren, C., Åkerud, H., Skalkidou, A., Bäckström, T., & Sundström-Poromaa, I. (2014) · Neuropsychobiology · doi:10.1159/000358838 · Cited by 137
Schwartz, R. D. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90684-3 · Cited by 141
Self-citationNeurosteroid Modulation of GABA IPSCs Is Phosphorylation Dependent
Fáncsik, A., Linn, D. M., & Tasker, J. G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03067.2000 · Cited by 142
“;3 min of achieving the whole-cell configuration (Marty and Neher, 1983).”
BackgroundProgesterone synthesis and myelin formation in peripheral nerves
Schumacher, M., Guennoun, R., MERCIER, G., Désarnaud, F., Lacor, P. N., Bénavidès, J., Ferzaz, B., Robert, F., & Baulieu, E. E. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00139-4 · Cited by 151
Sleep induction by an adrenal steroid in the rat
Mendelson, W. B., Martin, J. V., Perlis, M. L., Wagner, R., Majewska, M., & Paul, S. M. (1987) · Psychopharmacology · doi:10.1007/bf00179939 · Cited by 146
“The recent demonstration that two steroid metabolites bind to the "barbiturate site" at or near the chloride channel of the benzodiazepine (BZ) receptor complex at concentrations of 10 7-10 5 M (Majewska et al. 1986) suggests a new possible mechanism of hypnotic action.”
BackgroundSelf-citationThe Normal and Pathological Physiology of Brain Water
Go, K. G. (1997) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-7091-6549-2_2 · Cited by 151
Jones, E. A., & Weissenborn, K. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.3.279 · Cited by 134
Monteleone, P., Luisi, M., Colurcio, B., Casarosa, E., Monteleone, P., Ioime, R., Genazzani, A. R., & Maj, M. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200101000-00008 · Cited by 135
“Allopregnenolone is now recognized to be an important allosteric modulator of both GABA type-A and 5-HT type-3 receptors (3, 4), exhibiting neuroprotective, anxiolytic, anticonvulsant, and antidepressant actions (5).”
BackgroundPharmacokinetic and behavioral effects of allopregnanolone in healthy women
Timby, E., Balgård, M., Nyberg, S., Spigset, O., Andersson, A., Porankiewicz, J., Purdy, R. H., Zhu, D., Bäckström, T. C., & Poromaa, I. S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0148-7 · Cited by 142
“Through binding to the GABAA receptor complexes, allopregnanolone enhances inhibitory neurotransmission (Harrison and Simmonds 1984; Majewska et al. 1986), thus exerting anxiolytic (Bitran et al. 1991, 1995; Wieland et al. 1991), sedative (Lancel et al. 1997; Sundstrom et al. 1998), and…”
BackgroundFunctional Antagonism of Gonadal Steroids at the 5-Hydroxytryptamine Type 3 Receptor
Wetzel, C. H. R. (1998) · Molecular Endocrinology · doi:10.1210/me.12.9.1441 · Cited by 134
Althaus, A. L., Ackley, M. A., Belfort, G. M., Gee, S. M., Dai, J., Nguyen, D. P., Kazdoba, T. M., Modgil, A., Davies, P. A., Moss, S. J., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108333 · Cited by 135
“2 (PAMs) of both synaptic and extrasynaptic GABAA receptors with little or no direct activation (Belelli et al., 2009; Majewska et al., 1986).”
Modulation of inhibitory synaptic transmission in the hippocampus
Thompson, S. M. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90044-2 · Cited by 149
Effects of progesterone treatment on cocaine responses in male and female cocaine users
Sofuoglu, M., Mitchell, E. S., & Kosten, T. R. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.05.004 · Cited by 135
Behaviorally Selective Effects of Neuroactive Steroids on Plus-Maze Anxiety in Mice
Rodgers, R. J., & Johnson, N. J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00339-0 · Cited by 145
Ströhle, A., Romeo, E., di Michele, F., Pasini, A., Hermann, B., Gajewsky, G., Holsboer, F., & Rupprecht, R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.161 · Cited by 135
Marinelli, M., Piazza, P., Deroche, V, Maccari, S., Le Moal, M., & Simon, H. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02724.1994 · Cited by 133
“…been reported to modify the binding capacity of 5-HT receptors (Biegon et al., 1985; De Kloet et al., 1986; Martire et al., 1989) and GABA receptors (Majewska et al., 1986; Majewska, 1987, Sutanto et al., 1989) and to potentiate glutamatergic transmission (Tischler et al., 1988; Sapolsky, 1990).”
BackgroundArafat, E. S., Hargrove, J. T., Maxson, W. S., Desiderio, D. M., Wentz, A. C., & Andersen, R. N. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90448-6 · Cited by 134
Brain allopregnanolone regulates the potency of the GABAA receptor agonist muscimol
Pinna, G., Uzunova, V, Matsumoto, K., Puia, G., Mienville, J.-M., Costa, E., & Guidotti, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00149-5 · Cited by 135
Moore, F. L., & Evans, S. J. (1999) · Brain, Behavior and Evolution · doi:10.1159/000006610 · Cited by 135
“Metabolites of P4, especially 3α-OH metabolites, can interact with GABAA receptor/chloride channels and potentiate GABA-induced Cl– currents in neurons [Majewska et al., 1994] and spermatozoa [Wistrom and Meizel, 1993; Meizel, 1997].”
BackgroundBasile, A. S., & Jones, E. A. (1997) · Hepatology · doi:10.1002/hep.510250636 · Cited by 133
Baulieu, É.-É., & Schumacher, M. (2000) · Steroids · doi:10.1016/s0039-128x(00)00173-2 · Cited by 149
Poromaa, I. S. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00086-9 · Cited by 133
Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: A pilot study
Poromaa, I. S., Ashbrook, D. W., & Bäckström, T. C. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00035-2 · Cited by 133
Korneyev, A., Pan, B. S., Polo, A., Romeo, E., Guidotti, A., & Costa, E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13647.x · Cited by 132
Pathirathna, S., Brimelow, B. C., Jagodic, M. M., Krishnan, K., Jiang, X., Zorumski, C. F., Mennerick, S., Covey, D. F., Todorovic, S. M., & Jevtovic-Todorovic, V. (2005) · Pain · doi:10.1016/j.pain.2005.01.009 · Cited by 131
“3a5aP potentiates GABAA-induced currents in vitro (Majewska et al., 1986; Callachan et al., 1987; Wittmer et al., 1996), and here we show that 3a5aP also blocks T-type Ca2C currents.”
BackgroundBitran, D., Dugan, M., Renda, P., Ellis, R. C., & Foley, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02150-2 · Cited by 138
An Assessment of Anxiolytic Drug Screening Tests: Hormetic Dose Responses Predominate
Calabrese, E. J. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440802014238 · Cited by 132
“However, Majewska et al. (1986) opined that such biological changes are homeostatic and adaptive responses that permit endogenous regulatory factors to act in a coordinated fashion with positive and negative regulation of GABAergic neurotransmission.”
BackgroundFinasteride induced depression: a prospective study
Rahimi-Ardabili, B., Pourandarjani, R., Habibollahi, P., & Mualeki, A. (2006) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-6-7 · Cited by 140
GABA receptors, progesterone and premenstrual dysphoric disorder
Poromaa, I. S., Smith, S. S., & Gulinello, M. E. (2003) · Archives of Women s Mental Health · doi:10.1007/s00737-002-0147-1 · Cited by 142
“…notably benzodiazepines (BDZ), barbiturates and the neuroactive metabolites of steroid hormones, positively modulate the GABAA-R, increasing chloride ion influx and neuronal inhibition (Akwa et al., 1999; Bitran et al., 1995; Hevers and Luddens, 1998; Majewska et al., 1986; Mehta and Ticku, 1999).”
BackgroundProgesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells
Smith, S. S. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90377-z · Cited by 139
Lieberherr, M., Grosse, B., Duchambon, P., & Drüeke, T. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47076-2 · Cited by 132
Smith, S. S., Ruderman, Y., Frye, C. A., Homanics, G. E., & Yuan, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0168-3 · Cited by 146
“Positive modulators of the GABAR include most sedative, anxiolytic drugs, such as benzodiazepines (BDZ), barbiturates, ethanol, and the neuroactive metabolite of progesterone (P), 3α-OH-5α[β]-pregnan-20-one (THP or [allo]pregnanolone) (Majewska et al. 1986).”
BackgroundCharych, E. I., Liu, F., Moss, S. J., & Brandon, N. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.027 · Cited by 125
“…IH -PA Author M anuscript In addition to benzodiazepines, GABAARs are also sites for endogenous neuroactive steroids such as allopregnanolone, which potentiate the response to GABA with greater potency than benzodiazepine binding (Majewska et al., 1986; Morrow et al., 1990; Morrow et al., 1987).”
BackgroundAdministration of progesterone produces mild sedative-like effects in men and women
Gordh, A. S., Lindsey, S., Purdy, R. H., Hauger, R., & de Wit, H. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00033-7 · Cited by 139
“Interestingly, these metabolites of progesterone, known as neuroactive steroids, or neurosteroids, are also synthesized de novo in brain tissue (Majewska et al., 1986), and appear to play a role in the response to stress (Barbaccia et al.”
BackgroundAnticonvulsant and Behavioral Effects of Neuroactive Steroids Alone and in Conjunction with Diazepam
Gasior, M., Carter, R. B., Goldberg, S. R., & Witkin, J. M. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36837-5 · Cited by 131
Martinez Botella, G., Salituro, F. G., Harrison, B. L., Beresis, R. T., Bai, Z., Blanco, M.-J., Belfort, G. M., Dai, J., Loya, C. M., Ackley, M. A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00846 · Cited by 129
Premenstrual syndrome, a common but underrated entity: review of the clinical literature
Dilbaz, B., & Aksan, A. (2021) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2021.2020.0133 · Cited by 152
“Based on in vitro data and animal studies, there is evidence that cyclic variation in circulating estrogen and progesterone result in marked changes in the opioid (27), GABA (28) and serotonin (29) systems.”
BackgroundInfluentialProgesterone and the oligodendroglial lineage: Stage‐dependent biosynthesis and metabolism
Gago, N., Akwa, Y., Sananès, N., Guennoun, R., Baulieu, E. E., El‐Etr, M., & Schumacher, M. (2001) · Glia · doi:10.1002/glia.1117 · Cited by 127
“Both enzymes, 5a-reductase and 3a-HSOR, might thus work in concert to produce 3a,5a-THPROG, a well-characterized neuroactive steroid that acts as a potent positive allosteric modulator of GABAA receptors (Majewska et al. 1986; Lambert et al., 1999).”
BackgroundGonzález, S. L., Labombarda, F., González Deniselle, M. C., Guennoun, R., Schumacher, M., & De Nicola, A. F. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.02.024 · Cited by 126
Follesa, P., Serra, M., Cagetti, E., Pisu, M. G., Porta, S., Floris, S., Massa, F., Sanna, E., & Biggio, G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23238-7 · Cited by 128
“Moreover, given that AP exhibits pharmacological and biochemical profiles (Majewska et al., 1986) similar to those of benzodiazepines and barbiturates, an increase in the abundance of the a4 subunit might be a common mechanism underlying the development of tolerance, dependence, and withdrawal syndrome associated with…”
Metadata
- Authors
- Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1986-05-23
- Volume
- 232
- Issue
- 4753
- Pages
- 1004-1007
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2083447043
- Semantic Scholar
- 55b4fcd5a62357b63d7cb0aaf4869cfd9cf57ad2
- Cited by
- 2,225
- References
- 45
- Citations by year
- 2026: 15 · 2025: 31 · 2024: 26 · 2023: 28 · 2022: 37 · 2021: 35 · 2020: 38 · 2019: 47 · 2018: 35 · 2017: 28 · 2016: 40 · 2015: 33 · 2014: 48 · 2013: 51 · 2012: 52
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- steroid hormone metabolites, GABA receptors, progesterone, deoxycorticosterone, t-butylbicyclophosphorothionate, flunitrazepam binding, chloride uptake, neuronal excitability, hippocampal neurons, spinal cord neurons
- MeSH terms
- Animals, Bridged Bicyclo Compounds, Binding, Competitive, Brain, Cells, Cultured, Chlorides, Desoxycorticosterone, 20-alpha-Dihydroprogesterone, Drug Synergism, Flunitrazepam, Hippocampus, Ion Channels, Progesterone, Receptors, GABA-A, Spinal Cord, Bridged Bicyclo Compounds, Heterocyclic, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.